Emerging research shows mast cells play a role in the etiology of chronic rhinosinusitis with nasal polyps and may be a new ...

Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that the Company has initiated a Phase 2 study of barzolvolimab in atopic dermatitis (AD) and that the study is actively enrolling patients. AD ...

We welcome the submission of original research articles, reviews, methods papers, clinical trials, case series or general commentary related to the central topic of equine asthma with a particular ...

Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that the Company has initiated a Phase 2 study of barzolvolimab in atopic dermatitis (AD) and ...

The Spanish COPD guidelines recommend treatment of the mixed COPD–asthma phenotype with ICS and a long-acting bronchodilator (LABD) as a first option to improve lung function, respiratory ...

Asthma–chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) is a commonly encountered yet loosely defined clinical entity. ACOS accounts for approximately 15–25% of the ...

Asthma is a form of bronchial disorder caused by inflammation of the bronchi. It is characterized by spasmodic contraction of airway smooth muscle, difficulty breathing, wheezing and coughing ...

A panelist discusses how bronchiectasis involves a vicious cycle of airway damage, where neutrophilic inflammation leads to bronchial wall destruction and dilation, while explaining that diagnosis ...

Learn about the latest technology for migraine relief with neuromodulation device therapy. Understand potential risks and ...

Dec. 22, 2023 — There does not appear to be any profound differences between so-called exposure-based CBT and traditional CBT in the treatment of fibromyalgia. Both forms of treatment produced a ...

The Department of Health Sciences and Technology at ETH Zurich (www.hest.ethz.ch) invites applications for a Professorship on the topic of Human Integrative (Patho)physiology at the associate or full ...

October 5th 2023Treatment Strategies in Hepatocellular Carcinoma (HCC): Optimizing Outcomes and Resource Allocation ...